Cappella Lands $7,111,612 New Financing Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    41 Magnolia Dr. Westford, MA 01886
  • Company Description
    Cappella has developed a novel solution for the treatment of coronary bifurcated disease. In contrast to current approaches for treating bifurcations, Cappella´s Sideguard Sidebranch Stent conforms to the anatomy of the bifurcated segment.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor